APTT therapeutic range for monitoring unfractionated heparin therapy. Significant impact of the anti-Xa reagent used for correlation: Response from original authors Toulon et al
J Thromb Haemost
.
2021 Aug;19(8):2090-2091.
doi: 10.1111/jth.15350.
Authors
Pierre Toulon
1
,
Motalib Smahi
2
,
Neila De Pooter
3
Affiliations
1
Hematology Department, Université Côte d'Azur, CHU Nice, Nice, France.
2
Hematology Department, Simone Veil Hospital, Eaubonne, France.
3
Hematology Department, Centre Hospitalier, Grasse, France.
PMID:
34327830
DOI:
10.1111/jth.15350
No abstract available
Publication types
Letter
Comment
MeSH terms
Anticoagulants* / adverse effects
Heparin* / adverse effects
Heparin, Low-Molecular-Weight
Humans
Indicators and Reagents
Substances
Anticoagulants
Heparin, Low-Molecular-Weight
Indicators and Reagents
Heparin